Frequency and Referral Patterns of Neural Antibody Studies During the COVID-19 Pandemic: Experience From an Autoimmune Neurology Center.

Helena Ariño Raquel Ruiz García Beatriz Rioseras Laura NaranjoEugenia Martinez-HernandezAlbert SaizFrancesc GrausJosep Dalmau

Published in: Neurology(R) neuroimmunology & neuroinflammation (2023)

Our findings do not support that the COVID-19 pandemic led to a substantial increase of known or novel encephalitis mediated by antibodies against neural-surface antigens. The increase in Hu and GFAP antibodies likely reflects the progressive increased recognition of the corresponding disorders.

Keyphrases

multiple sclerosis
primary care
dendritic cells
drug induced
immune response
light emitting